Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Br J Haematol] 2020 Jul; Vol. 190 (2), pp. 284-293. <i>Date of Electronic Publication: </i>2020 Mar 03.
- MeSH Terms: Anticoagulants / *therapeutic use ; Cardiac Surgical Procedures / *methods ; Hemorrhage / *chemically induced ; Warfarin / *therapeutic use ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants / pharmacology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Warfarin / pharmacology ; Young Adult
- References: Abdul-Jawad Altisent, O., Durand, E., Muñoz-García, A.J., Nombela-Franco, L., Cheema, A., Kefer, J., Gutierrez, E., Benítez, L.M., Amat-Santos, I.J., Serra, V., Eltchaninoff, H., Alnasser, S.M., Elízaga, J., Dager, A., García del Blanco, B., Ortas-Nadal, M. del R., Marsal, J.R., Campelo-Parada, F., Regueiro, A., Del Trigo, M., Dumont, E., Puri, R. & Rodés-Cabau, J. (2016) Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement. JACC: Cardiovascular Interventions, 9, 1706-1717. ; Charlesworth, M. & Arya, R. (2018) Direct oral anticoagulants: peri-operative considerations and controversies. Anaesthesia, 73, 1460-1463. ; Dale, B.J., Chan, N.C. & Eikelboom, J.W. (2016) Laboratory measurement of the direct oral anticoagulants. British Journal of Haematology, 172, 315-336. ; Douketis, J.D., Murphy, S.A., Antman, E.M., Grip, L.T., Mercuri, M.F., Ruff, C.T., Weitz, J.I., Braunwald, E. & Giugliano, R.P. (2018) Peri-operative adverse outcomes in patients with atrial fibrillation taking warfarin or edoxaban: analysis of the ENGAGE AF-TIMI 48 trial. Thrombosis & Haemostasis, 118, 1001-1008. ; Douketis, J.D., Spyropoulos, A.C., Duncan, J., Carrier, M., Le Gal, G., Tafur, A.J., Vanassche, T., Verhamme, P., Shivakumar, S., Gross, P.L., Lee, A.Y.Y., Yeo, E., Solymoss, S., Kassis, J., Le Templier, G., Kowalski, S., Blostein, M., Shah, V., MacKay, E., Wu, C., Clark, N.P., Bates, S.M., Spencer, F.A., Arnaoutoglou, E., Coppens, M., Arnold, D.M., Caprini, J.A., Li, N., Moffat, K.A., Syed, S. & Schulman, S. (2019) Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Internal Medicine, 179, 1469. ; Godier, A., Dincq, A.-S., Martin, A.-C., Radu, A., Leblanc, I., Antona, M., Vasse, M., Golmard, J.-L., Mullier, F. & Gouin-Thibault, I. (2017) Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. European Heart Journal, 38, 2431-2439. ; He, H., Ke, B., Li, Y., Han, F., Li, X. & Zeng, Y. (2018) Novel oral anticoagulants in the preoperative period: a meta-analysis. Journal of Thrombosis & Thrombolysis, 45, 386-396. ; Keeling, D., Tait, R.C., Watson, H.; British Committee of Standards for Haematology. (2016) Peri-operative management of anticoagulation and antiplatelet therapy. British Journal of Haematology, 175, 602-613. ; Lopes, C.T., Dos Santos, T.R., Brunori, E.H., Moorhead, S.A., Lopes, J.deL. & Barros, A.L. (2015) Excessive bleeding predictors after cardiac surgery in adults: integrative review. Journal of Clinical Nursing, 24, 3046-3062. ; Lopes, C.T., Brunori, E.F., Cavalcante, A.M., Moorhead, S.A., Swanson, E., Lopes, J.de L. & de Barros, A.L. (2016) Factors associated with excessive bleeding after cardiac surgery: a prospective cohort study. Heart & Lung, 45, 64-69.e2. ; Manning, S., Hayes, C., Arachchillage, D., Patel, K., Jones, D. (2017) Guidelines for the use of Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation (AF), and for the treatment and prevention of Venous Thromboembolism (VTE). In Royal Brompton & Harefield NHS Trust Intranet: Royal Brompton & Harefield NHS Trust. ; Nashef, S.A.M., Roques, F., Sharples, L.D., Nilsson, J., Smith, C., Goldstone, A.R. & Lockowandt, U. (2012) EuroSCORE II. European Journal of Cardio-Thoracic Surgery, 41, 734-44. ; Oh, C.S., Choi, J.W., Jung, E., Kang, W.S. & Kim, S.H. (2015) Warfarin therapy and perioperative transfusion requirement with bleeding amount in patients undergoing cardiac surgery with cardiopulmonary bypass: a retrospective study. Transfusion Medicine, 25, 33-37. ; Steffel, J., Verhamme, P., Potpara, T.S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K.G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., Sinnaeve, P., Collins, R., Camm, A.J., Heidbüchel, H., Lip, G.Y.H., Weitz, J., Fauchier, L., Lane, D., Boriani, G., Goette, A., Keegan, R., MacFadyen, R., Chiang, C.-E., Joung, B. & Shimizu, W.; ESC Scientific Document Group. (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace, 20, 1231-1242. ; Zhao, Y., Yang, Y., Tang, X., Xiang, Y., Zhang, L. & Xiao, H. (2017) New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin. Journal of Interventional Cardiac Electrophysiology, 48, 267-282.
- Contributed Indexing: Keywords: bleeding; cardiac surgery; direct-acting oral anticoagulant; thrombosis; warfarin
- Substance Nomenclature: 0 (Anticoagulants) ; 5Q7ZVV76EI (Warfarin)
- Entry Date(s): Date Created: 20200305 Date Completed: 20210302 Latest Revision: 20210302
- Update Code: 20231215
|